Intellia Therapeutics

IPO

Revolutionize the course of medicine

Intellia Therapeutics was founded in 2014, is headquartered in Cambridge, United States, lists 201–500 employees, and has $85.0M in recorded funding across 2 rounds.

Employees
201–500
Founded
2014
Business Model
B2B
Total Funding
$85.0M
Last Round
$70.0M Series BSep 2015
Rounds
2
Type
Public
Ticker
NTLA · NASDAQ

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

Intellia Therapeutics develops novel, potentially curative treatments that use CRISPR-based gene editing to change DNA inside cells, either in the body (in vivo) or outside the body (ex vivo) from a patient or donor. The company is advancing late-stage in vivo CRISPR programs for hereditary angioedema and ATTR amyloidosis, and it employs proprietary technologies across a range of severe diseases. Intellia’s mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments.

Summary

Intellia Therapeutics is a Biotech company based in Cambridge, United States, founded in 2014. It lists 201–500 employees. It has raised $85.0M in total across 2 rounds, most recently a $70.0M Series B round in Sep 2015. Investors include OrbiMed, Atlas Venture and Janus Fund.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Post-IPO DebtSenior Secured Term Loan FacilitySep 2026
$400.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Intellia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/intellia-therapeutics"><img src="https://indexed.vc/api/badge/company/intellia-therapeutics" alt="Intellia Therapeutics on Indexed.vc" width="260" height="76" /></a>